Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bio-Path Holdings - 16 Year Stock Price History | BPTH

Historical daily share price chart and data for Bio-Path Holdings since 2008 adjusted for splits and dividends. The latest closing stock price for Bio-Path Holdings as of May 01, 2024 is 2.76.
  • The all-time high Bio-Path Holdings stock closing price was 22960.00 on May 13, 2008.
  • The Bio-Path Holdings 52-week high stock price is 44.80, which is 1523.2% above the current share price.
  • The Bio-Path Holdings 52-week low stock price is 2.35, which is 14.9% below the current share price.
  • The average Bio-Path Holdings stock price for the last 52 weeks is 13.50.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Bio-Path Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 6.4127 9.8500 11.2000 2.4900 2.7600 -70.19%
2023 22.7298 30.0000 45.2000 7.1000 9.2600 -69.34%
2022 65.0679 83.0000 88.6000 26.4000 30.2000 -59.95%
2021 113.4654 72.6000 235.4000 72.6000 75.4000 7.71%
2020 97.5477 165.2000 165.2000 61.4000 70.0000 -56.20%
2019 234.5905 76.0000 777.2000 35.0000 159.8000 128.29%
2018 545.5173 839.6000 996.0000 63.2000 70.0000 -91.36%
2017 2090.0414 5000.0000 5080.0000 800.0000 810.0000 -85.00%
2016 6980.9175 5120.0000 11760.0000 3890.4000 5400.0000 8.00%
2015 6073.6508 10640.0000 10640.0000 4000.0000 5000.0000 -53.01%
2014 11657.8095 16120.0000 19760.0000 7840.0000 10640.0000 -33.50%
2013 4016.1937 1280.0000 16000.0000 1200.0000 16000.0000 1042.86%
2012 1343.7168 1400.0000 1680.0000 520.0000 1400.0000 0.00%
2011 1496.8698 1400.0000 2200.0000 1040.0000 1400.0000 -0.57%
2010 1625.3571 1720.0000 2400.0000 1000.0000 1408.0000 -18.14%
2009 1318.5079 2200.0000 4000.0000 480.0000 1720.0000 -21.82%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.002B $0.000B
BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Path's drug delivery technology distributes nucleic acid drugs systemically, throughout the human body, via simple intravenous infusion. The delivery technology can be applied both to double stranded and single stranded nucleic acid compounds with the potential to revolutionize the treatment of cancer and other diseases where drugable targets of disease are well characterized.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $72.830B 29.93
Chugai Pharmaceutical (CHGCY) Japan $52.113B 23.29
Takeda Pharmaceutical (TAK) Japan $41.396B 6.71
Merck (MKGAF) Germany $20.808B 19.63
Astellas Pharma (ALPMY) Japan $17.282B 27.29
Sandoz Group AG (SDZNY) Switzerland $14.602B 0.00
Shionogi (SGIOY) Japan $13.688B 12.28
Neurocrine Biosciences (NBIX) United States $13.686B 56.83
United Therapeutics (UTHR) United States $10.396B 11.81
Catalent (CTLT) United States $10.107B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.755B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.982B 7.08
Revolution Medicines (RVMD) United States $6.356B 0.00
Ionis Pharmaceuticals (IONS) United States $6.014B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.342B 0.00
Alpine Immune Sciences (ALPN) United States $4.235B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.451B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.803B 0.00
Summit Therapeutics (SMMT) United States $2.759B 0.00
PTC Therapeutics (PTCT) United States $2.466B 0.00
Corcept Therapeutics (CORT) United States $2.427B 24.55
Indivior (INDV) United States $2.421B 11.48
Dyne Therapeutics (DYN) United States $2.181B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.947B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.857B 11.00
Evotec AG (EVO) Germany $1.839B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.835B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.819B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.776B 18.35
Avadel Pharmaceuticals (AVDL) Ireland $1.645B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.597B 27.95
Ardelyx (ARDX) United States $1.497B 0.00
Soleno Therapeutics (SLNO) United States $1.492B 0.00
Xencor (XNCR) United States $1.291B 0.00
4D Molecular Therapeutics (FDMT) United States $1.224B 0.00
Pacira BioSciences (PCRX) United States $1.221B 12.15
Ironwood Pharmaceuticals (IRWD) United States $1.213B 11.40
Collegium Pharmaceutical (COLL) United States $1.208B 7.43
Cronos Group (CRON) Canada $1.123B 0.00
Cassava Sciences (SAVA) United States $0.958B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.919B 0.00
Relay Therapeutics (RLAY) United States $0.863B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.852B 0.00
ARS Pharmaceuticals (SPRY) United States $0.843B 0.00
Sage Therapeutics (SAGE) United States $0.839B 0.00
Enliven Therapeutics (ELVN) United States $0.817B 0.00
USANA Health Sciences (USNA) United States $0.799B 12.94
Ocular Therapeutix (OCUL) United States $0.733B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.728B 0.00
Silence Therapeutics (SLN) United Kingdom $0.654B 0.00
Savara (SVRA) United States $0.633B 0.00
Siga Technologies (SIGA) United States $0.624B 9.24
Exscientia (EXAI) United Kingdom $0.598B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.594B 0.00
Lyell Immunopharma (LYEL) United States $0.553B 0.00
OmniAb (OABI) United States $0.520B 0.00
Verve Therapeutics (VERV) United States $0.504B 0.00
KalVista Pharmaceuticals (KALV) United States $0.479B 0.00
ProKidney (PROK) United States $0.474B 0.00
Altimmune (ALT) United States $0.464B 0.00
Korro Bio (KRRO) United States $0.456B 0.00
Larimar Therapeutics (LRMR) United States $0.440B 0.00
Lexeo Therapeutics (LXEO) United States $0.410B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.410B 0.00
Tourmaline Bio (TRML) United States $0.406B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.389B 0.00
Esperion Therapeutics (ESPR) United States $0.373B 0.00
Nature's Sunshine Products (NATR) United States $0.366B 20.47
Harrow (HROW) United States $0.361B 0.00
Heron Therapeutics (HRTX) United States $0.349B 0.00
Fractyl Health (GUTS) United States $0.324B 0.00
Lyra Therapeutics (LYRA) United States $0.315B 0.00
Bioventus (BVS) United States $0.314B 0.00
Organogenesis (ORGO) United States $0.310B 58.75
Aquestive Therapeutics (AQST) United States $0.306B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.295B 0.00
Black Diamond Therapeutics (BDTX) United States $0.293B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.291B 0.00
ESSA Pharma (EPIX) Canada $0.284B 0.00
Nanobiotix S.A (NBTX) France $0.275B 0.00
Nektar Therapeutics (NKTR) United States $0.268B 0.00
Akebia Therapeutics (AKBA) United States $0.264B 0.00
Metagenomi (MGX) United States $0.263B 0.00
Pyxis Oncology (PYXS) United States $0.262B 0.00
Xeris Biopharma Holdings (XERS) United States $0.259B 0.00
Adherex Technologies (FENC) United States $0.249B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Foghorn Therapeutics (FHTX) United States $0.232B 0.00
Conduit Pharmaceuticals (CDT) United States $0.222B 0.00
Galectin Therapeutics (GALT) United States $0.217B 0.00
Avita Medical (RCEL) United States $0.217B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Acrivon Therapeutics (ACRV) United States $0.206B 0.00
Zevra Therapeutics (ZVRA) United States $0.199B 0.00
Eliem Therapeutics (ELYM) United States $0.197B 0.00
Telomir Pharmaceuticals (TELO) United States $0.196B 0.00
Century Therapeutics (IPSC) United States $0.189B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.184B 0.00
Incannex Healthcare (IXHL) Australia $0.183B 0.00
Profound Medical (PROF) Canada $0.182B 0.00
MediWound (MDWD) Israel $0.177B 0.00
Prelude Therapeutics (PRLD) United States $0.159B 0.00
Regulus Therapeutics (RGLS) United States $0.151B 0.00
Achieve Life Sciences (ACHV) Canada $0.150B 0.00
CytoDyn (CYDY) United States $0.139B 0.00
Elite Pharmaceuticals (ELTP) United States $0.139B 12.97
Cardiol Therapeutics (CRDL) Canada $0.137B 0.00
VAXART, INC (VXRT) United States $0.126B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.123B 2.59
Karyopharm Therapeutics (KPTI) United States $0.120B 0.00
Citius Pharmaceuticals (CTXR) United States $0.119B 0.00
GlycoMimetics (GLYC) United States $0.116B 0.00
FibroGen (FGEN) United States $0.111B 0.00
Relmada Therapeutics (RLMD) United States $0.110B 0.00
Inotiv (NOTV) United States $0.099B 0.00
OptiNose (OPTN) United States $0.093B 0.00
PMV Pharmaceuticals (PMVP) United States $0.093B 0.00
AlloVir (ALVR) United States $0.091B 0.00
Vivani Medical (VANI) United States $0.089B 0.00
Aclaris Therapeutics (ACRS) United States $0.086B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.085B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Assertio Holdings (ASRT) United States $0.084B 6.81
ProPhase Labs (PRPH) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.077B 0.00
Tempest Therapeutics (TPST) United States $0.077B 0.00
Journey Medical (DERM) United States $0.074B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.064B 0.95
Mural Oncology (MURA) Ireland $0.063B 0.00
Jaguar Animal Health (JAGX) United States $0.059B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
BioLineRx (BLRX) Israel $0.054B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Unicycive Therapeutics (UNCY) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
Surrozen (SRZN) United States $0.034B 0.00
Protara Therapeutics (TARA) United States $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
CASI Pharmaceuticals (CASI) China $0.032B 0.00
JanOne (JAN) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.031B 0.00
DURECT (DRRX) United States $0.030B 0.00
NRx Pharmaceuticals (NRXP) United States $0.027B 0.00
Nutriband (NTRB) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Lipocine (LPCN) United States $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
PolyPid (PYPD) Israel $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.67
TherapeuticsMD (TXMD) United States $0.022B 0.00
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 1.03
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Avalo Therapeutics (AVTX) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.004B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Clever Leaves Holdings (CLVR) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.04
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 45.23